Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Several melatonin receptors agonists (ramelteon, prolonged-release melatonin, agomelatine and tasimelteon) have recently become available for the treatment of insomnia, depression and circadian rhythms sleep-wake disorders. The efficacy and safety profiles of these compounds in the treatment of the...
Main Authors: | Moshe Laudon, Anat Frydman-Marom |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/9/15924 |
Similar Items
-
MELATONIN DAN MELATONIN RECEPTOR AGONIST SEBAGAI PENANGANAN INSOMNIA PRIMER KRONIS
by: Ni Luh Putu Ayu Maha Iswari, et al.
Published: (2013-04-01) -
The Effectiveness of Prolonged-Release Melatonin in Primary Insomnia Patients with a Regular Sleep-Wake Cycle
by: Seockhoon Chung, et al.
Published: (2016-06-01) -
Melatonin effects on sleep disorders in children with attention deficit hyperactivity disorder
by: Zahra Bahremand, et al.
Published: (2014-09-01) -
SLEEP DISORDERS: AN INTERDISCIPLINARY PROBLEM
by: E. Y. YAKUPOV
Published: (2016-12-01) -
SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE
by: N. V. Fedorova, et al.
Published: (2014-07-01)